Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R B Innis

Showing results (91-100 of 133) with videos related to

Pageof 14
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|December 15, 1993
Single photon emission computed tomographic imaging demonstrates loss of striatal dopamine transporters in Parkinson diseaseR B Innis, J P Seibyl, B E Scanley, et al.
Journal of Medicinal Chemistry|May 27, 1994
N-omega-fluoroalkyl analogs of (1R)-2 beta-carbomethoxy-3 beta-(4-iodophenyl)-tropane (beta-CIT): radiotracers for positron emission tomography and single photon emission computed tomography imaging of dopamine transportersJ L Neumeyer, S Wang, Y Gao, et al.
The American Journal of Psychiatry|June 10, 1998
Increased striatal dopamine transmission in schizophrenia: confirmation in a second cohortA Abi-Dargham, R Gil, J Krystal, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 25, 2000
PET quantification of 5-HT2A receptors in the human brain: a constant infusion paradigm with [18F]altanserinC H van Dyck, P Z Tan, R M Baldwin, et al.
The American Journal of Psychiatry|September 1, 1995
[123I]beta-CIT SPECT imaging of striatal dopamine transporter binding in Tourette's disorderR T Malison, C J McDougle, C H van Dyck, et al.
European Journal of Pharmacology|September 22, 1994
In vivo quantification of dopamine D2 receptor parameters in nonhuman primates with [123I]iodobenzofuran and single photon emission computerized tomographyM Laruelle, M S al-Tikriti, Y Zea-Ponce, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|May 1, 1994
SPECT quantification of [123I]iomazenil binding to benzodiazepine receptors in nonhuman primates: II. Equilibrium analysis of constant infusion experiments and correlation with in vitro parametersM Laruelle, A Abi-Dargham, M S al-Tikriti, et al.
Epilepsia|October 21, 1999
Effects of vigabatrin on the GABAergic system as determined by [123I]iomazenil SPECT and GABA MRSN P Verhoeff, O A Petroff, F Hyder, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 1, 1995
Reproducibility of SPECT measurement of benzodiazepine receptors in human brain with iodine-123-iomazenilA Abi-Dargham, M Gandelman, S S Zoghbi, et al.
Biological Psychiatry|February 9, 2000
SPECT [I-123]iomazenil measurement of the benzodiazepine receptor in panic disorderJ D Bremner, R B Innis, T White, et al.
Pageof 14

Showing results (91-100 of 133) with videos related to

Sort By:
Pageof 14
Proceedings of the National Academy of Sciences of the United States of America|December 15, 1993
Single photon emission computed tomographic imaging demonstrates loss of striatal dopamine transporters in Parkinson diseaseR B Innis, J P Seibyl, B E Scanley, et al.
Journal of Medicinal Chemistry|May 27, 1994
N-omega-fluoroalkyl analogs of (1R)-2 beta-carbomethoxy-3 beta-(4-iodophenyl)-tropane (beta-CIT): radiotracers for positron emission tomography and single photon emission computed tomography imaging of dopamine transportersJ L Neumeyer, S Wang, Y Gao, et al.
The American Journal of Psychiatry|June 10, 1998
Increased striatal dopamine transmission in schizophrenia: confirmation in a second cohortA Abi-Dargham, R Gil, J Krystal, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 25, 2000
PET quantification of 5-HT2A receptors in the human brain: a constant infusion paradigm with [18F]altanserinC H van Dyck, P Z Tan, R M Baldwin, et al.
The American Journal of Psychiatry|September 1, 1995
[123I]beta-CIT SPECT imaging of striatal dopamine transporter binding in Tourette's disorderR T Malison, C J McDougle, C H van Dyck, et al.
European Journal of Pharmacology|September 22, 1994
In vivo quantification of dopamine D2 receptor parameters in nonhuman primates with [123I]iodobenzofuran and single photon emission computerized tomographyM Laruelle, M S al-Tikriti, Y Zea-Ponce, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|May 1, 1994
SPECT quantification of [123I]iomazenil binding to benzodiazepine receptors in nonhuman primates: II. Equilibrium analysis of constant infusion experiments and correlation with in vitro parametersM Laruelle, A Abi-Dargham, M S al-Tikriti, et al.
Epilepsia|October 21, 1999
Effects of vigabatrin on the GABAergic system as determined by [123I]iomazenil SPECT and GABA MRSN P Verhoeff, O A Petroff, F Hyder, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 1, 1995
Reproducibility of SPECT measurement of benzodiazepine receptors in human brain with iodine-123-iomazenilA Abi-Dargham, M Gandelman, S S Zoghbi, et al.
Biological Psychiatry|February 9, 2000
SPECT [I-123]iomazenil measurement of the benzodiazepine receptor in panic disorderJ D Bremner, R B Innis, T White, et al.
Pageof 14